Effect of combined Allium canadanse and Malva sylvestis in Comparison with tamsulosin in urinary stones

Phase 2

Recruiting

• Conditions: ureteral stones.; Calculus of ureter; N20.1

• Registration Number: IRCT20081011001323N22
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age more than18 years old
Suffering from ureteral stone less than 10 millimeter
Having informed consent form

Exclusion Criteria

Uncontrolled coagulopathy
Azotemia
Pregnancy
Presence of active urinary tract infection
Allergy to medical or herbal drugs
Suffering from cardiovascular or pulmonary disease
Suffering from hepatic disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Passage of ureteral stones with sizes from 4 to 10 millimeters. Timepoint: Two weeks and one month after start of treatment. Method of measurement: Perform KUB and sonography and patient report.

Secondary Outcome Measures

Name	Time	Method
The severity of pain due to stone passage. Timepoint: During the study , two weeks and one month after starting treatment. Method of measurement: With Visual Analogue Scale (VAS).